Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tamsulosin Hydrochloride 0.4 MG
DRUG
3 trials
Sponsors
Kocatepe University
, CHU de Quebec-Universite Laval
, Bir Hospital
Conditions
Benign Prostatic Hyperplasia
Choroid Disease
Pupil Anomaly
Ureteral Stent-Related Symptom
Urinary Retention
Phase 2
Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery
NCT03314025
CHU de Quebec-Universite Laval
Urinary Retention
Start: 2017-10-06
End: 2022-10-01
Target: 158
Updated: 2021-05-19
Phase 3
Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms
Recruiting
NCT06803030
Bir Hospital
Ureteral Stent-Related Symptom
Start: 2025-08-30
End: 2026-12-31
Target: 189
Updated: 2025-09-08
Phase 4
The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil
Completed
NCT03144596
Kocatepe University
Benign Prostatic Hyperplasia, Choroid Disease, Pupil Anomaly
Start: 2015-10-29
End: 2016-11-19
Updated: 2017-05-09
Related Papers
TEMPOUR: A Randomized Controlled Trial Assessing Perioperative Use of an Alpha-1 Blocker to Reduce Postoperative Urinary Retention After Transanal Endoscopic Microsurgery Procedures
Diseases of the Colon & Rectum
2025-01-02